LNAI Lunai Bioworks Inc.

Price (delayed)

$2.92

Market cap

$13.24M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$60.8

Enterprise value

$11.5M

?
Relative Growth: Rel. Growth: 0
Relative Strength: Rel. Strength: 3
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 18

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B ...

Highlights
The debt has dropped by 80% year-on-year and by 49% since the previous quarter
Lunai Bioworks's quick ratio has surged by 78% YoY
The equity has dropped by 111% year-on-year but it has grown by 29% since the previous quarter
The company's EPS has shrunk by 137% YoY
Lunai Bioworks's net income has plunged by 91% YoY and by 2.2% from the previous quarter

Key stats

What are the main financial stats of LNAI

LNAI stock price

How has the Lunai Bioworks stock price performed over time
Intraday
1.74%
1 week
-3.95%
1 month
12.31%
1 year
-87.68%
YTD
-58.58%
QTD
-10.43%

Financial performance

How have Lunai Bioworks's revenue and profit performed over time
Revenue
$20,942
Gross profit
$20,942
Operating income
-$133.48M
Net income
-$128.28M
Gross margin
100%
Net margin
-612,568.1%
Lunai Bioworks's net income has plunged by 91% YoY and by 2.2% from the previous quarter
LNAI's operating income has shrunk by 69% YoY but it is up by 2% QoQ

Price vs fundamentals

How does LNAI's price correlate with its fundamentals

Growth

What is Lunai Bioworks's growth rate over time

Valuation

What is Lunai Bioworks stock price valuation
P/E
N/A
P/B
N/A
P/S
435.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
548.9
The company's EPS has shrunk by 137% YoY
The equity has dropped by 111% year-on-year but it has grown by 29% since the previous quarter

Efficiency

How efficient is Lunai Bioworks business performance

Dividends

What is LNAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LNAI.

Financial health

How did Lunai Bioworks financials performed over time
LNAI's total assets is 49% lower than its total liabilities
LNAI's total assets has shrunk by 92% YoY but it is up by 48% QoQ
Lunai Bioworks's quick ratio has surged by 78% YoY
The debt is 115% greater than the equity
The equity has dropped by 111% year-on-year but it has grown by 29% since the previous quarter
The debt has dropped by 80% year-on-year and by 49% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.